{"id":"NCT00617981","sponsor":"Imunon","briefTitle":"Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)","officialTitle":"A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDoxÂ® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-05","primaryCompletion":"2013-01","completion":"2016-08","firstPosted":"2008-02-18","resultsPosted":"2017-03-24","lastUpdate":"2024-05-03"},"enrollment":701,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hepatocellular Carcinoma"],"interventions":[{"type":"DRUG","name":"ThermoDox","otherNames":[]},{"type":"DRUG","name":"5% Dextrose Solution","otherNames":[]}],"arms":[{"label":"ThermoDox + RFA","type":"EXPERIMENTAL"},{"label":"Sham + RFA","type":"SHAM_COMPARATOR"}],"summary":"The purpose of this study is to determine whether ThermoDox, a thermally sensitive liposomal doxorubicin, is effective in the treatment of non-resectable hepatocellular carcinoma when used in conjunction with radiofrequency ablation (RFA).","primaryOutcome":{"measure":"Progression Free Survival Will be Measured From the Date of Randomization to the First Date on Which One of the Following Occurs. o Local Recurrence o Any New Distant Intrahepatic HCC Tumor o Any New Extrahepatic HCC Tumor o Death From Any Cause","timeFrame":"3 years","effectByArm":[{"arm":"ThermoDox + RFA","deltaMin":13.97,"sd":null},{"arm":"Sham + RFA","deltaMin":13.87,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":23},"locations":{"siteCount":79,"countries":["United States","Canada","China","Hong Kong","Italy","Japan","Malaysia","Philippines","South Korea","Taiwan","Thailand"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":118,"n":343},"commonTop":["Alopecia","Pyrexia","Aspartate Aminotransferase Increased","Alanine Aminotransferase Increased","Abdominal Pain"]}}